Australian Clinical Labs Ltd has released a press release.
HLS: Supplementary Target's Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Australian Clinical Labs Ltd on 6ix
Earlier from Australian Clinical Labs
- FY23 investor results presentation
- Appendix 4E and FY23 financial reports
- HLS: ACCC Statement of Issues
- Takeover bid for Healius Ltd- extension of offer period
- AXX: ACL's proposed acquisition of Healius raises concerns
Later from Australian Clinical Labs
- Third Supplementary Bidder's Statement
- Notice of fulfilment of conditions
- Takeover offer for Healius - extension of offer period
- Extension of offer period - notice of variation
- Fourth Supplementary Bidder's Statement
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs